Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Community Archives
Print | Email | Share | Comments (10)

FDA Issues Warning About Test Strips That Can Give False Readings, Lead to Insulin Overdoses

Aug 24, 2009

The FDA warning is based on 13 deaths between 1997 and 2009 that were reported in healthcare facilities where patients used the test strips. People with diabetes who are at highest risk are those undergoing dialysis or recovering from recent surgery.

The U.S. Food and Drug Administration has issued a warning against the use of GDH-PQQ blood glucose test strips by people with diabetes who are taking medications that contain non-glucose sugars. [Note: GDH-PQQ is the abbreviation of "glucose dehydrogenase pyrroloquinoline quinone," a chemical that reacts with the non-glucose sugars maltose, galactose, and xylose, which are contained in some therapeutic products.]

Because the strips can mistake non-glucose sugars for glucose, they can give an inaccurately high BG reading that could lead to an insulin overdose.

The FDA warning is based on 13 deaths between 1997 and 2009 that were reported in healthcare facilities where patients were using the test strips. People with diabetes who are at highest risk are those undergoing dialysis or recovering from recent surgery.

According to the FDA alert, "Non-glucose sugars contained in some therapeutic products, such as peritoneal dialysis solutions and certain immunoglobulins, can falsely elevate glucose results, which may prompt excessive insulin administration. These therapeutic products, which are labeled to indicate that they may interfere with this particular glucose monitoring technology, are mostly used in patients with serious medical conditions, including kidney failure and moderate to severe rheumatoid arthritis."

List of GDH-PQQ Glucose Test Strips

The FDA noted that the following test strips and their associated meters use GDH-PQQ methodology as of August 2009.

Roche Diagnostics

  1. ACCU-CHEK Comfort Curve test strips, for use with:
    • ACCU-CHEK Inform meters [model 2001201]
    • ACCU-CHEK Complete meters [models 200 and 250]
    • ACCU-CHEK Advantage meters [models 888, 831, 850, and 768]
    • ACCU-CHEK Voicemate meters [model 0009221]
  2. ACCU-CHEK Aviva test strips, for use with:
    • ACCU-CHEK Aviva meters [models 525, 535, and 555]
  3. ACCU-CHEK Compact test strips, for use with:
    • ACCU-CHEK Compact meters [model GF]
    • ACCU-CHEK Compact Plus meters [models GP and GT]
  4. ACCU-CHEK Go test strips, for use with:
    • ACCU-CHEK Go meters [model GJ]
  5. ACCU-CHEK Active test strips, for use with:
    • ACCU-CHEK Active meters [models GG and GN]

Abbott Diabetes Care

  1. Freestyle test strips, for use with:
    • FreeStyle meters
    • FreeStyle Flash meters
    • FreeStyle Freedom meters
  2. Freestyle Lite test strips, for use with:
    • FreeStyle Lite meters
    • FreeStyle Freedom Lite meters

Home Diagnostics

  1. TRUEtest test strips, for use with:
    • TRUEresult meters
    • TRUE2go meters

Smiths Medical

  1. Abbott Diabetes Care Freestyle test strips, for use with:
    • CoZmonitor blood glucose module (for use with the Deltec Cozmo Insulin Pump)

Insulet

  1. Abbott Diabetes Care Freestyle test strips, for use with:
    • OmniPod Insulin Management System

The FDA notes that test strips may be distributed under multiple trade names. Because manufacturers of GDH-PQQ test strips currently on the market may subsequently change to non-GDH-PQQ methodology, the FDA recommends that healthcare providers and patients refer to the labeling on their test devices or consult with test strip manufacturers to confirm the type of BG measuring methodology they use.

The FDA warning and the agency's patient advice are available online.

Manufacturer Responses

Glucose test strip manufacturers have begun to respond to the FDA warning. Bayer Diabetes Care said, "Since 2006, Bayer Diabetes Care has not distributed test strips that use GDH-PQQ (glucose dehydrogenase pyrroloquinoline quinone) glucose monitoring technology for its blood glucose meters."

Arkray stated "The GLUCOCARD 01 and Assure families of products use a glucose-specific enzyme and can, therefore, distinguish between glucose and other sugars. In light of the FDA's announcement, ARKRAY will upgrade any consumer concerned about their GDH system to a product from the GLUCOCARD 01 family at no charge."


Categories: Blood Glucose, Blood Sugar, Community, Diabetes, Diabetes, Food, Government & Policy, Health, Insulin, Insulin Pumps, Losing weight, Meters, Type 1 Issues, Type 2 Issues



You May Also Be Interested In...


Click Here To View Or Post Comments

Comments 10 comments - Aug 24, 2009

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.